Evidence map›Paper›PMID 33713388›Full record

ArticleThe FEBS journal2021

The lysosomal endopeptidases Cathepsin D and L are selective and effective proteases for the middle-down characterization of antibodies.

Tomislav Čaval, Elizabeth Sara Hecht, Wilfred Tang, Maelia Uy-Gomez, Andrew Nichols, Yong J Kil, Wendy Sandoval, Marshall Bern, Albert J R Heck

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Tomislav ČavalBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.ORCID 0000-0003-2132-1391
Elizabeth Sara HechtDepartment of Microchemistry, Proteomics, and Lipidomics & Next Generation Sequencing, Genentech, Inc., South San Francisco, CA, USA.
Wilfred TangProtein Metrics Inc., San Carlos, CA, USA.
Maelia Uy-GomezDepartment of Microchemistry, Proteomics, and Lipidomics & Next Generation Sequencing, Genentech, Inc., South San Francisco, CA, USA.
Andrew NicholsProtein Metrics Inc., San Carlos, CA, USA.
Yong J KilProtein Metrics Inc., San Carlos, CA, USA.
Wendy SandovalDepartment of Microchemistry, Proteomics, and Lipidomics & Next Generation Sequencing, Genentech, Inc., South San Francisco, CA, USA.
Marshall BernProtein Metrics Inc., San Carlos, CA, USA.
Albert J R HeckBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands.ORCID 0000-0002-2405-4404
Protein Metrics (United States) · USAgenzia Regionale per la Protezione dell'ambiente ligure · ITUtrecht University · NL

Funding

New Algorithms and Software for Mass Spectrometric Analysis of Intact Proteins and ComplexesR43GM133239 · NIGMS · PROTEIN METRICS, LLC · PI BERN, MARSHALL WAYNE · 2019 to 2019
$225k
NIGMS NIH HHS R43 GM133239
6 · The paper itself

Abstract

Mass spectrometry is gaining momentum as a method of choice to de novo sequence antibodies (Abs). Adequate sequence coverage of the hypervariable regions remains one of the toughest identification challenges by either bottom-up or top-down workflows. Methods that efficiently generate mid-size Ab fragments would further facilitate top-down MS and decrease data complexity. Here, we explore the proteases Cathepsins L and D for forming protein fragments from three IgG1s, one IgG2, and one bispecific, knob-and-hole IgG1. We demonstrate that high-resolution native MS provides a sensitive method for the detection of clipping sites. Both Cathepsins produced multiple, albeit specific cleavages. The Abs were cleaved immediately after the CDR3 region, yielding ~ 12 kDa fragments, that is, ideal sequencing-sized. Cathepsin D, but not Cathepsin L, also cleaved directly below the Ab hinge, releasing the F(ab')2. When constrained by the different disulfide bonds found in the IgG2 subtype or by the tertiary structure of the hole-containing bispecific IgG1, the hinge region digest product was not produced. The Cathepsin L and Cathepsin D clipping motifs were related to sequences of neutral amino acids and the tertiary structure of the Ab. A single pot (L + D) digestion protocol was optimized to achieve 100% efficiency. Nine protein fragments, corresponding to the VL, VH, CL, CH1, CH2, CH3, CL + CH1, and F(ab')2, constituted ~ 70% of the summed intensities of all deconvolved proteolytic products. Cleavage sites were confirmed by the Edman degradation and validated with top-down sequencing. The described work offers a complementary method for middle-down analysis that may be applied to top-down Ab sequencing. ENZYMES: Cathepsin L-EC 3.4.22.15, Cathepsin D-EC 3.4.23.5.

Indexed as

Amino Acid SequenceAntibodiesCathepsin DCathepsin LEndopeptidasesHumansImmunoglobulin GLysosomesMass SpectrometryPeptide HydrolasesProteolysisAntibodiesCathepsin DCathepsin LEndopeptidasesImmunoglobulin GPeptide HydrolasesantibodiesCathepsinhigh-resolution native mass spectrometrymiddle-down sequencingtop-down sequencing

Identifiers

PMID33713388
PMCPMC8518856
OpenAlexW3134706350

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.